Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -54.49%-484.4K | -30.24%-223.01K | -1,054.86%-133.95K | -37.45%-103.29K | 56.55%-24.15K | -179.17%-313.56K | -291.59%-171.23K | -9.30%-11.6K | -224.69%-75.15K | -59.56%-55.58K |
| Net income from continuing operations | 27.43%-277.81K | 98.50%-2.66K | -145.96%-134.51K | 13.09%-94.98K | -8.89%-45.66K | -197.13%-382.83K | -354.71%-176.93K | -165.47%-54.69K | -243.72%-109.29K | -11.71%-41.93K |
| Remuneration paid in stock | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --29.4K | ---- | ---- |
| Other non cashItems | ---- | ---- | ---- | ---- | ---- | --627.19K | --627.19K | ---- | 200.00%1 | --1 |
| Change In working capital | -398.23%-206.59K | -727.88%-220.35K | -95.96%553 | -124.34%-8.31K | 257.65%21.51K | 319.18%69.27K | 828.24%35.09K | 37.00%13.68K | 294.62%34.14K | -604.25%-13.65K |
| -Change in receivables | 60.88%-732 | -14.11%-2.14K | --0 | --0 | 888.20%1.4K | -117.96%-1.87K | ---1.87K | -96.42%403 | 18.18%-225 | 68.50%-178 |
| -Change in payables and accrued expense | -389.36%-205.86K | -690.33%-218.21K | -95.84%553 | -124.18%-8.31K | 249.32%20.11K | 1,064.96%71.14K | 867.07%36.97K | 1,144.93%13.28K | 284.99%34.36K | -511.71%-13.47K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -254.45%-484.4K | -148.91%-223.01K | -1,054.86%-133.95K | -37.46%-103.29K | 56.55%-24.15K | 379.24%313.63K | 1,142.70%455.95K | -9.30%-11.6K | -224.67%-75.15K | -59.56%-55.58K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | ||||||||||
| Cash from discontinued investing activities | ||||||||||
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -15.16%456K | 45.18%210.71K | 105,258.72%181.22K | -59.17%61.22K | -98.82%2.85K | 427.20%537.5K | 512.34%145.14K | -99.08%172 | 1,866.17%149.94K | 365.68%242.25K |
| Net issuance payments of debt | --137.3K | 4,730.26%136.78K | 375.00%817 | -259.69%-3.15K | 252.10%2.85K | --0 | ---2.95K | -99.08%172 | -74.14%1.97K | -98.44%810 |
| Net common stock issuance | ---- | ---- | ---- | --0 | ---- | --389.41K | ---- | ---- | --491.36K | ---- |
| Proceeds from stock option exercised by employees | --0 | ---- | ---- | ---- | ---- | --148.1K | ---- | ---- | ---- | ---- |
| Net other financing activities | -18.16%318.7K | --73.94K | --180.4K | -56.50%64.37K | ---- | 281.94%389.41K | --0 | ---- | --147.97K | --241.44K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -15.16%456K | 45.18%210.71K | 105,259.30%181.22K | -59.17%61.22K | -98.82%2.85K | 427.20%537.5K | 512.34%145.14K | -99.08%172 | 1,866.17%149.94K | 365.68%242.25K |
| Net cash flow | ||||||||||
| Beginning cash position | 2,139.28%220.93K | -23.03%197.45K | -40.93%159.02K | 4.25%197.46K | 2,139.28%220.93K | -44.69%9.87K | 813.02%256.54K | 1,321.75%269.22K | 507.77%189.41K | -44.69%9.87K |
| Current changes in cash | -112.69%-28.4K | 52.99%-12.3K | 513.63%47.27K | -156.25%-42.08K | -111.41%-21.3K | 2,260.74%223.87K | -30.65%-26.16K | -242.93%-11.43K | 581.95%74.79K | 986.04%186.67K |
| Effect of exchange rate changes | 49.16%-6.51K | 109.09%859 | -604.70%-8.84K | -27.67%3.63K | 69.58%-2.17K | -636.11%-12.81K | -627.16%-9.45K | -207.46%-1.25K | 52.63%5.02K | -84.67%-7.13K |
| End cash Position | -15.81%186.01K | -15.81%186.01K | -23.03%197.45K | -40.93%159.02K | 4.25%197.46K | 2,139.28%220.93K | 2,139.28%220.93K | 813.02%256.54K | 1,321.75%269.22K | 507.77%189.41K |
| Free cash from | -254.45%-484.4K | -148.91%-223.01K | -1,054.86%-133.95K | -37.46%-103.29K | 56.55%-24.15K | 379.24%313.63K | 1,142.70%455.95K | -9.30%-11.6K | -224.67%-75.15K | -59.56%-55.58K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.